Q3 2021 Holdings
Filed 2021-11-15 | 47 holdings | $81.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Aadi Bioscience(WHWK) | COM | 00032Q104 | $44.9M | 1,529,402 | 55.2% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $18.2M | 337,500 | 22.4% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $7.6M | 121,500 | 9.3% |
| Cabaletta BIO(CABA) | COM | 12674W109 | $3.7M | 302,926 | 4.5% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $2.5M | 140,839 | 3.1% |
| Altimmune(ALT) | COM NEW | 02155H200 | $1.7M | 150,000 | 2.1% |
| Bicycle Therapeutics PLC Sponsored ADS(BCYC) | SPONSORED ADS | 088786108 | $1.6M | 38,184 | 2.0% |
| C4 Therapeutics STK(CCCC) | COM STK | 12529R107 | $938.0K | 21,000 | 1.2% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $32.1K | 11,728,033 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $18.4K | 1,135,000 | 0.0% |
| Bellus Health(BLU) | COM NEW | 07987C204 | $12.3K | 2,007,500 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $9.2K | 374,495 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $9.1K | 322,500 | 0.0% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $8.7K | 393,250 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $8.4K | 843,122 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $7.9K | 1,316,268 | 0.0% |
| Seelos Therapeutics Inc | COM | 81577F109 | $6.9K | 2,860,000 | 0.0% |
| Cyteir Therapeutics Inc | COM | 23284P103 | $6.9K | 391,974 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $6.4K | 417,409 | 0.0% |
| Verastem Inc | COM | 92337C104 | $6.2K | 2,018,433 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.5K | 562,500 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $5.5K | 291,884 | 0.0% |
| Selecta Biosciences Inc(SELBUSD) | COM | 816212104 | $4.3K | 1,024,668 | 0.0% |
| Vincerx Pharma Inc | COM NEW | 92731L106 | $4.2K | 260,000 | 0.0% |
| Olema Pharmaceuticals(OLMA) | COM | 68062P106 | $4.1K | 150,500 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $3.9K | 206,126 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $3.9K | 392,500 | 0.0% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $3.9K | 369,863 | 0.0% |
| Krystal Biotech(KRYS) | COM | 501147102 | $3.8K | 72,551 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $2.8K | 297,362 | 0.0% |
| Rain Therapeutics Inc | COM | 75082Q105 | $2.7K | 182,500 | 0.0% |
| Gossamer BIO(GOSS) | COM | 38341P102 | $2.7K | 215,000 | 0.0% |
| Merus N V | COM | N5749R100 | $2.7K | 122,000 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $2.5K | 75,500 | 0.0% |
| Avadel Pharmaceuticals PLCCall | SPONSORED ADR | 05337M104 | $2.5K | 250,000 | 0.0% |
| Viridian Therapeutics(VRDN) | COM | 92790C104 | $2.2K | 135,807 | 0.0% |
| Allakos(ALLKGUSD) | COM | 01671P100 | $1.9K | 17,500 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $1.8K | 17,500 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $1.5K | 365,000 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $1.5K | 60,000 | 0.0% |
| Astria Therapeutics | COM | 06435X102 | $1.4K | 156,927 | 0.0% |
| Chimerix(CMRXEUR) | COM | 16934W106 | $1.3K | 210,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.1K | 301,904 | 0.0% |
| Elanco Animal Health(ELAN) | COM | 28414H103 | $925 | 29,000 | 0.0% |
| United Therapeutics del(UTHR) | COM | 91307C102 | $554 | 3,000 | 0.0% |
| Novavax Inc(NVAX) | COM NEW | 670002401 | $480 | 2,315 | 0.0% |
| Nuvation BIO Inc(NUVB/WS) | *W EXP 07/07/202 | 67080N119 | $242 | 90,832 | 0.0% |